Genomic & Biopharma News

Foxconn backs digital X-ray startup Nanox’s $26M round
Nanox, an Israeli medical imaging company, has raised $26 million to help fuel the development and commercialization of its Star Trek-inspired digital X-ray bed.
Fierce Biotech, 2020-01-17 14:49:34

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
ORB Company News, 2016-12-28 18:58:47

JPM: Biotech, VC execs on where the industry should look beyond cancer
SAN FRANCISCO—Oncology is clearly a major medical and societal issue: a major killer that, while predominately affecting the older population, can strike the young through a mixture of environmental factors or a genetic lottery. It’s no wonder we struggle to even call it by its name, preferring just the "big C."
Fierce Biotech, 2020-01-17 14:46:56

Bayer's 'tumor-agnostic' cancer med Vitrakvi turned away in England, Germany
Bayer is among drugmakers marketing new "tumor-agnostic" medicines that target specific types of tumors, regardless of their location in the body. But the company's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.
Fierce Pharma, 2020-01-17 14:44:58

Study sets the record straight on unproven therapy to treat sepsis
The Jan. 17 issue of the Journal of the American Medical Association features an important study about sepsis with an accompanying editorial by a University of Nebraska Medical Center expert.
News Medical Life Sciences, 2020-01-17 14:30:34

Researchers visualize molecular organization of TNFα receptor molecules
Whether a sick cell dies, divides, or travels through the body is regulated by a sophisticat-ed interplay of signal molecules and receptors on the cell membrane.
News Medical Life Sciences, 2020-01-17 14:04:00

Amblyopia treatment may need to be revised, research suggests
When University of California, Irvine neurobiologist Carey Y.L. Huh, Ph.D., set her sights on discovering more about amblyopia, she brought personal insight to her quest. As a child, Huh was diagnosed with the condition, which is often called "lazy eye."
News Medical Life Sciences, 2020-01-17 14:00:52

Hengrui's Sun Piaoyang, China's richest pharma leader, steps down after 30-year run—sort of
Sun Piaoyang, who's led Jiangsu Hengrui Medicine for 30 years and forms half of China's fourth-wealthiest family, is stepping down as the domestic pharma major's chairman. Though he still retains control of the company, the transition comes at a critical time for Hengrui.
Fierce Pharma, 2020-01-17 13:54:26

Research: Firms’ strategic decisions affect evolution of activism and emergence of mobilization
According to received wisdom, local activism against the establishment of industrial plants follows a cycle, with its highest intensity a short time after mobilization.
News Medical Life Sciences, 2020-01-17 13:41:00

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
News Medical Life Sciences, 2020-01-17 13:38:46